Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)
Manufactures prescription drugs and provides contract manufacturing services for pharmaceutical companies.
59.65+0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+12.2%
The outlook
ROVI.MC trades at 59.65, positioned low within its 52-week range and below its moving averages, suggesting mixed near-term momentum. Analysts lean Buy with an average target around 25% above the current price, though coverage is moderate at nine analysts. The stock carries a trailing P/E of 16.4 and sits in neutral territory overall.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 9 analysts
Price trendMixed vs its moving averages
52-week range23% of the way from its 52-week low to high
Price targetAvg target +25% vs current price
Analyst price target
~12-month · 9 analysts74.36average target+24.7% vs now
Now 59.65
Low 64.20High 83.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.05B
52-wk high
86.70
52-wk low
51.65
50-day avg
57.79
200-day avg
67.24
Trailing P/E
16.4